Tech Company Financing Transactions

Harbinger Health Funding Round

Harbinger Health, operating out of Cambridge, received $140 million in funding from Flagship Pioneering, Partners Investment and Pictet.

Transaction Overview

Company Name
Announced On
9/28/2023
Transaction Type
Venture Equity
Amount
$140,000,000
Round
Series B
Investors

Flagship Pioneering (Lead Investor)

Partners Investment (Lead Investor)

Pictet (Lead Investor)

Catalyst Investors

Proceeds Purpose
The company intends to use the funds for the completion of its Cancer ORigin Epigenetics-Harbinger Health (CORE-HH) 10,000-participant clinical study of its novel blood-based cancer screening platform, develop its two-tier testing model, expand its data science and commercial teams and capabilities, and initiate additional clinical studies in high-risk populations.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 Spinelli Place
Cambridge, MA 02138
USA
Phone
Undisclosed
Email Address
Overview
Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis and management. Incubated within Flagship Pioneering for three years before launching in 2021, Harbinger combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test.
Profile
Harbinger Health LinkedIn Company Profile
Social Media
Harbinger Health Company Twitter Account
Company News
Harbinger Health News
Facebook
Harbinger Health on Facebook
YouTube
Harbinger Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Hahn
  Stephen Hahn LinkedIn Profile  Stephen Hahn Twitter Account  Stephen Hahn News  Stephen Hahn on Facebook
Chief Financial Officer
Vince Lozada
  Vince  Lozada LinkedIn Profile  Vince  Lozada Twitter Account  Vince  Lozada News  Vince  Lozada on Facebook
Chief Medical Officer
May Orfali
  May Orfali LinkedIn Profile  May Orfali Twitter Account  May Orfali News  May Orfali on Facebook
Chief Operating Officer
Gisela Paulsen
  Gisela Paulsen LinkedIn Profile  Gisela Paulsen Twitter Account  Gisela Paulsen News  Gisela Paulsen on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/28/2023: The Grand World venture capital transaction
Next: 9/28/2023: Hydrexia venture capital transaction

 

Share this article

 


About Database of VC Transactions

We record every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary